Lipocine Inc. (LPCN) Stock Overview
Explore Lipocine Inc.’s financial performance, market position, analyst ratings, and future outlook.
Lipocine Inc. (LPCN)
Key Financials
Key Financials
Market Cap
17.3M
P/E Ratio
-1.11
EPS (TTM)
$-1.79
ROE
-0.65%
LPCN Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Lipocine Inc. (NASDAQ: LPCN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Lipocine Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of LPCN on the NASDAQ shows an RSI of 42.21, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.78 for the NASDAQ listing.
Key metrics behind Lipocine Inc.'s NASDAQ-traded stock include a P/E ratio of -1.11 and a market capitalization of 17.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of LPCN on the NASDAQ.